Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I- restricted viral determinants

Journal of Experimental Medicine

Volumn 189, Issue 11, 1999, Pages 1757-1764

  Chen, Weisan ^a   Yewdell, Jonathan W ^a,c   Levine, Rodney L ^b   Bennink, Jack R ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antigen processing; Cysteine immunology; Major histocompatibility complex immunology; Peptides immunology; Viral vaccines immunology

Indexed keywords

CYSTEINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; FEMALE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, VIRAL; CELL LINE; CYSTEINE; FEMALE; H-2 ANTIGENS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

EID: 0033532627     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.11.1757     Document Type: Article

References (14)

1. Rammensee, H.-G., J. Bachmann, and S. Stevanovic. 1997. MHC Ligands and Peptide Motifs. Landes Bioscience, Austin, Texas.
2. Madden, D.R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587-622.
3. Engelhard, V.H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13-23.
4. Meadows, L., W. Wang, J.M. den Haan, E. Blokland, C. Reinhardus, J.W. Drijfhout, J. Shabanowitz, R. Pierce, A.I. Agulnik, C.E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity. 6:273-281.
5. Fisk, B., T.L. Blevins, J.T. Wharton, and G.G. Ioannides. 1995. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines J. Exp. Med. 181:2109-2117.
6. Chen, W., S. Khilko, J. Fecondo, D.H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by non-dominant anchor residues. J. Exp. Med. 180:1471-1483.
7. Anton, L.C., J.W. Yewdell, and J.R. Bennink. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158: 2535-2542.
8. Deng, Y., J.W. Yewdell, L.C. Eisenlohr, and J.R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507-1515.
9. Porgador, A., J.W. Yewdell, Y. Deng, J.R. Bennink, and R.N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 6:715-726.
10. Gallimore, A., T. Dumrese, H. Hengartner, R.M. Zinkernagel, and H.G. Rammensee. 1998. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187:1647-1657.
11. Manning, T.C., B. A. Schodin, and D.M. Kranz. 1996. A strategy for the synthesis and screening of thiol-modified peptide variants recognized by T cells. J. Immunol. Methods. 192:125-132.
12. Freedman, R.B. 1989. Protein disulfide isomerase: multiple roles in the modification of nascent secretory protein. Cell. 57:1069-1072.
13. Gao, X.M., P. Wordsworth, A.J. McMichael, M.M. Kyaw, M. Seifert, D. Rees, and G. Dougan. 1996. Homocysteine modification of HLA antigens and its immunological consequences. Eur. J. Immunol. 26:1443-1450.
14. Di Modugno, F., C. Mammi, L. Rosano, O. Rubiu, P. Nistico, and A. Chersi. 1997. MHC-peptide binding: dimers of cysteine-containing nonapeptides bind with high affinity to HLA-A2.1 class I molecules. J. Immunother. 20:431-436.